CVS Health (CVS)
$65.57
1.09 (1.66%)
CVS Stock Quote Delayed 30 Minutes
3 Short Trades for a Dicey Market
Markets remain in turmoil and that's creating many bearish opportunities. Here are three weak stocks to consider for short trades.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$63.86
Market Cap
81.30B
PE Ratio
17.93
EPS
3.656
Volume (Avg. Vol.)
8.12M
Day's Range
$63.76 - $65.03
52-Week Range
$42.93 - $77.01
Dividend & Yield
$2.66 (4.06%)
CVS Stock Predictions, Articles, and CVS Health News
Why Aetna Inc Stock Will Rebound Soon
CVS's acquisition of Aetna is all but a sure thing, and AET stock is set to surge as a result. Here's what investors need to know.
CVS Health (CVS) remains a Sell This Week
CVS Health (CVS) a Sell this week based on the latest comparative pricing of its shares and analysis.
This week, CVS Health (CVS) stays a Sell
CVS Health (CVS) a Sell at $67.05 based on the most current comparative pricing of its shares and news.
At $ 67.510, CVS Health (CVS) a Sell
At $ 67.510, CVS Health (CVS) a Sell based on the most recent comparative pricing of its shares and analysis.
CVS Health (CVS) a Sell at $67.65
This week, CVS Health (CVS) stays a Sell based on the latest stock market rankings, and relative pricing of its shares.
This Week, Aetna (AET) drops to a Buy
Aetna (AET) a Buy at $175.98 based on the most current SEC filings, and comparative pricing of its shares.
Sell for CVS Health (CVS) This Week
At $67.73, CVS Health (CVS) a Sell based on the latest relative pricing of its shares and stock market rankings.
Earnings Show That Time Is Running Out for Fitbit Inc
After disappointing earnings, Fitbit's hope is that monitoring of chronic conditions can make the company a cheap pick-up for an insurer or Amazon seeking lower health care costs.
Sell for CVS Health (CVS) This Week
CVS Health (CVS) a Sell at $68.76 based on the latest relative pricing of its shares and SEC filings.
Albertson’s Buyout Is a Terrible Deal for Rite Aid Stock Owners
The news of a Rite Aid buyout is not good for shareholders. Details of the deal show that owners of Rite Aid stock will not be paid what the company is worth.
Rumored AmerisourceBergen Deal Is Not What Walgreens Needs Right Now
The reports of Walgreens Boots Alliance buying out AmerisourceBergen failed to move WBA stock...with good reason.
Metrics for Sales Growth Make CVS Health (CVS) a Sell at recent price of $70.11
CVS Health Corp's Sell recommendation is the conclusion of a process of analysis that is proprietary and produced outcomes that were above average in 2 areas: ranking in its industry group that is in the top third, and analytical scoring that is near average; and produced below average conclusions in 4 areas: an economic sector ranked below average in attractiveness, an industry group rated below average in attractiveness, a ranking in the company's sector that is in the bottom quarter, and a mathematical computation of risk/reward that is unattractive.
AmerisourceBergen Corp. Stock Soars on Possible Walgreens Takeover
AmerisourceBergen (ABC) stock was on the rise Tuesday on news of a possible takeover approach by Walgreens Boots Alliance (WBA).
Are Healthcare Stocks Terminally Ill?
Healthcare stocks were rocked hard this week, but they will recover. The news that Amazon, Berkshire Hathaway and JPMorgan are forming their own healthcare company will not hold other healthcare stocks down for the long-term.
Investors Need to Be Patient With the CVS and Aetna Inc Merger
While Aetna's numbers aren't great, the merger of CVS and AET should be a good long-term play. There is long-term synergy in combining pharmacy and health benefits with preventative care.
PBM Stocks Have Much to Fear from Buffett, JPMorgan, Amazon Venture
The new venture being launched by Warren Buffett, JPMorgan Chase and Amazon.com will badly hurt PBM stocks, including ESRX, CVS and WBA.
Keep an Eye Out for a Short-Term Relief Rebound in the Dow
Stocks suffered a rare bout of weakness on Tuesday - the worst loss since Aug. 17 and the first back-to-back declines of more than 0.5% since before Election Day.
UnitedHealth Group Inc Stock Is Already Set for a Comeback
UnitedHealth (UNH) stock is down on an Amazon (AMZN) headline. I bet this dip is not the start of something more sinister, so here's how you can catch this proverbial falling knife.
